Eagle Pharmaceuticals, Inc. (EGRX) Stock Overview
OTC Pink · Healthcare · Drug Manufacturers - Specialty & Generic
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Eagle Pharmaceuticals, Inc.
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on manufacturing, developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company's product portfolio offers RYANODEX for…
Source: Yahoo Finance
Sector & Industry
Eagle Pharmaceuticals, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry group. It is listed on the OTC Pink exchange.
Eagle Pharmaceuticals, Inc. at a Glance
| Company | Eagle Pharmaceuticals, Inc. |
| Ticker | EGRX |
| Exchange | OTC Pink |
| Currency | USD |
| Price | $0.25 |
| Market cap | $3.29M |
| P/E ratio (trailing) | 1.25 |
| EPS (trailing) | $0.20 |
| 52-week high | $3.73 |
| 52-week low | $0.00 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.84 |
| Return on equity (ROE) | 4.88% |
| Debt-to-equity | 28.75% |
| Average volume | 6,133 |
| Shares outstanding | 13.16M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 134 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Eagle Pharmaceuticals, Inc.'s current P/E ratio?
- Eagle Pharmaceuticals, Inc. (EGRX) has a trailing P/E ratio of 1.25 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Eagle Pharmaceuticals, Inc.'s market capitalisation?
- Eagle Pharmaceuticals, Inc.'s market cap is $3.29M based on our latest snapshot. See how it ranks by market cap →
- What is EGRX's 52-week range?
- Over the past 52 weeks, EGRX has traded between $0.00 and $3.73. What does the 52-week range mean? →
- How volatile is Eagle Pharmaceuticals, Inc. compared to the market?
- Eagle Pharmaceuticals, Inc. has a beta of 0.84, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Eagle Pharmaceuticals, Inc. pay a dividend?
- Eagle Pharmaceuticals, Inc. does not currently pay a dividend according to our latest data.
- What exchange is EGRX listed on?
- EGRX is listed on the OTC Pink. Browse all OTC Pink-listed stocks →
- What sector is Eagle Pharmaceuticals, Inc. in?
- Eagle Pharmaceuticals, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →